Fasting blood samples of the participants were analyzed for gastrointestinal hormones, glucose, lipids and inflammatory markers.
In addition, gut microbiota and their metabolites, namely short-chain fatty acids, were measured in stool samples. This research was conducted under the Collaborative Research Center 1052, Obesity Mechanism.
“Further studies are needed to investigate whether treatments that alter the microbiome could open new avenues for less invasive approaches to obesity prevention and treatment. A better understanding of the underlying mechanisms between the microbiome, the gut, and the brain may lead to new developments.” “Strategies that promote healthy eating habits in at-risk people” said Witte.